Navigation Links
Cardica Receives NASDAQ Notification
Date:5/22/2009

REDWOOD CITY, Calif., May 22 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that, on May 19, 2009, it received a notice from the Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) that the Company does not comply with the minimum $10 million stockholders' equity requirement for continued listing on the NASDAQ Global Market as stated under NASDAQ Marketplace Rule 5450(b)(1)(A) (the "Minimum Equity Requirement").

As provided by NASDAQ rules, Cardica has the opportunity to submit to NASDAQ on or before June 3, 2009, a specific plan and timeline to regain and sustain compliance with the Minimum Equity requirement. There is no assurance that NASDAQ will accept the Company's plan to satisfy the stockholders' equity requirement. If NASDAQ accepts Cardica's plan, NASDAQ may grant Cardica a period of up to 105 days from May 19, 2009 to regain compliance with such listing requirements. If NASDAQ determines that Cardica's plan is not sufficient to achieve and sustain compliance with the Minimum Equity Requirement, NASDAQ will provide written notice that Cardica's securities will be subject to delisting from the NASDAQ Global Market. At such time, Cardica may then apply to move to The NASDAQ Capital Market, provided it meets the continued listing requirements of that market, or appeal NASDAQ's delisting determination to a NASDAQ Listing Qualifications Panel. In the event of an appeal, Cardica's securities would remain listed on The NASDAQ Global Market pending a decision by the Panel following the hearing.

About Cardica

Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in the United States and Europe and its PAS-Port(R) Proximal Anastomosis System is marketed in the United States, Europe and Japan.

Forward-Looking Statements

This press release contains "forward-looking statements," including, without limitation, statements related to Cardica's plan to submit a compliance plan to NASDAQ, the continued listing of Cardica's common stock on The NASDAQ Global Market and potential outcomes following that submission. The words "may," "intends" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including, without limitation, the risk that the NASDAQ Staff may reject the Company's plan for meeting the minimum continued listing requirements and the risk that Cardica otherwise fails to comply with the continued listing requirements of The NASDAQ Global Market or any other NASDAQ market, as well as other risks detailed from time to time in Cardica's SEC reports, including its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2009. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. You are encouraged to read Cardica's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.


'/>"/>
SOURCE Cardica, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardica to Announce Fiscal 2009 Third Quarter Financial Results on Monday, May 4, 2009
2. Cardica to Announce Fiscal 2009 Second Quarter Financial Results on Thursday, January 29, 2009
3. Cardica Announces Publication of Case Report in the Journal of Neurosurgery Featuring Use of C-Port(R) System in Brain Arterial Bypass
4. Cardica to Present at William Blair Small-Cap Growth Stock Conference
5. Cardica to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Provide Positive Update on Pas-Port(R)
6. Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday, August 5, 2008
7. Cardica Names Frederick Bauer Vice President of Operations
8. Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons
9. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
10. Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, April 29, 2008
11. Cardicas C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology: